Insiders · DYN

John Cox

CEO & President, Director at Dyne Therapeutics, Inc. (DYN) since March 2024

John Cox has filed 30 insider reports with the SEC since June 2021, as CEO & President and director at Dyne Therapeutics, Inc. (DYN) and director at Sigilon Therapeutics, Inc. (SGTX). In the last 12 months John Cox sold $536K of stock on the open market. On November 13, 2026 John Cox filed a Form 144 notice and plans to sell 5,513 DYN shares (~$92.8K). In the latest filing, on November 16, 2026, John Cox sold 5,513 shares of Dyne Therapeutics, Inc. (DYN) for $92.7K at an average of $16.82.

Planned sale (Form 144)

  • John Cox plans to sell 5,513 DYN shares (~$92.8K), around Nov 13, 2026. Notice filed Nov 13, 2026.

A Form 144 is a notice of a proposed sale, not a trade. The sale itself shows up in a later Form 4.

Filings
30
Companies
2
Bought on market
$1.97M
Sold on market
$674K

Companies where John Cox is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Dyne Therapeutics, Inc. logo
DYN
Dyne Therapeutics, Inc.
CEO & President, Directorsince March 2024351,994$1.97M$674K$14.91$15.50+4.0%Nov 16, 2026
Sigilon Therapeutics, Inc. logo
SGTX
Sigilon Therapeutics, Inc.
Director0Aug 11, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare John Cox with

Other insiders at the same companies

Questions about John Cox

What is John Cox's role at Dyne Therapeutics, Inc.?
John Cox reports to the SEC as CEO & President and director at Dyne Therapeutics, Inc. (DYN), according to the latest filing on November 16, 2026. John Cox has also filed as director at Sigilon Therapeutics, Inc. (SGTX).
How many shares does John Cox own?
After the latest filing that states it, John Cox directly owned 351,994 shares of Dyne Therapeutics, Inc. (DYN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has John Cox bought or sold stock recently?
The most recent open-market purchase was on July 15, 2025: bought 100,000 shares of Dyne Therapeutics, Inc. (DYN) for $911K at an average of $9.11. The most recent open-market sale was on November 13, 2026: sold 5,513 shares of Dyne Therapeutics, Inc. (DYN) for $92.7K at an average of $16.82.
How do I get alerts when John Cox files?
Follow John Cox on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. John Cox filed 4 times in the last 90 days.

From SEC Forms 3, 4, 5 and 144 filed by John Cox (SEC CIK 0001498428). Totals count each trade once, skipping amendments whose original is on file, from Jun 28, 2021 on. View on SEC EDGAR · Get this as JSON